JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

download JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

of 16

Transcript of JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    1/16

    Supervisor :

    Dr. Pandiaman Pandia Sp.P(K)

    JURNAL READING VI

    Early detection of central airway lung cancer in smokers with silicosisA.L.L. Lo, Y. Huang, S.Y. Lam, A.H.K. Cheung, R.Au, C. C. Leung, W. K. Lam, M. S. M. Lp, M. Chan-Yeung,B.Lam

    dr.MohammadRamadhaniSoeroso

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    2/16

    MATERIALS AND METHODS

    From June 2006 to March 2009, all patients

    followed up at the designated

    Pneumoconiosis Clinic of Hong Kong were

    invited to join the study if they fulfilled the

    following inclusion criteria: 1) age 40 years;

    2) smoking history of20 pack-years; and 3)

    confirmed diagnosis of silicosis. The

    diagnosis of silicosis was based on significant

    occupational exposure to silica-containingdust and radiographic changes consistent

    with silicosis, with or without histological

    proof.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    3/16

    Subjects were asked to provide early morning

    sputum for 3 consecutive days. All fresh specimens

    were examined by trained cytotechnologists underthe supervision of a pathologist (SYL) in the

    Cytology Laboratory of the Department of Health.

    The results were reported as unsatisfactory,

    normal, atypia, suspicious for cancer and cancer.all sputum samples were sent for cytometry

    examination using an automated high-resolution

    image cytometer.

    SPUTUM

    EXAMINATION

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    4/16

    Was performed under local anaesthesia

    in the endoscopy suite. ConventionalWLB was performed first, followed by

    autoflourescence bronchoscopy. All

    abnormal sites were videotaped,recorded, and biopsied.

    BRONCHOSCOPY

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    5/16

    Standard spirometry was performedbefore bronchoscopy. FEV1 & FVC

    were measured and expressed as a

    percentage of the predicted value based

    on a prediction equation for the Chinesepopulation. Airflow limitation was defined

    as a ratio of FEV1 to FVC of

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    6/16

    MANAGEMENT

    Subjects with intraepitheliel lung cancer(severe

    dysplasia and CIS) were treated with endobrochial

    cryotherapy and reassesed periodically with WLB and

    autoflourescence bronchoscopy every 3, 6, 12, and 24

    months. Subjects with pre-neoplastic lesions(squamousmetaplasia and dysplasia) were followed up with WLB

    and autoflourescence bronchoscopy every 6 months

    until the lesion regressed. All abnormal sites detected

    and sites that received treatment were biopsied at re-assessment. Physicians advice for smoking cessation

    were given to all participants in the study.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    7/16

    OUT COME

    The outcome of this cohort,

    including the number of

    patients with lung cancer andthe stage distribution, was

    determined from patient

    records reviewed in July

    2009.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    8/16

    ETHICAL CONSIDERATIONS

    Ethical approval was

    obtained from institutional

    review board of both theDepartment of Health and the

    University of Hong Kong.

    Informed consent was obtainedfrom each subject.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    9/16

    STATISTICAL ANALYSIS

    Subjects were divided into 2 groups for analyses.

    Group 1 includes patients with endobronchial

    biospy revealing squamous metaplasia or above.

    Group 2 are those without endobronchial lesion orbiopsy showing hyperplasia or below. Continous

    data were expressed as mean standard

    deviation(SD) and categorical data were

    presented as percentage. Fishers exact test andthe 2 independent sample t-tests were used to

    compare dichotomous and continuous data

    between the 2 groups.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    10/16

    RESULTS

    From June 2006 to March 2009, we screened 720subjects with silicosis. A final total of 48 eligibleChinese male subjects with sputum abnormalitieswere recruited into the study. The mean age of thiscohort was 63 10 years (range 4882), with an

    accumulated smoking history of 51 30 pack-years.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    11/16

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    12/16

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    13/16

    DISCUSSION

    Squamous cell carcinoma develops in agradual and stepwise fashion therefore if thepre-cancerous and pre-invasive lesions can be

    detected in eary stages and treated, thedevelopment of lung cancer may be arrested.

    Combination of sputum cytology/ cytometryand autofluorescencebronchoscopy as a

    screening tool, shows 4.2% of the silicoticpatients with sputum abnormality hadintraepithelial (Stage 0) lung cancer.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    14/16

    DISCUSSIONIn our cohort, squamous metaplasia and mildto moderate dysplasia were detected in 29.2%of the subjects and up to 9% of patientsprogress to intraepithelial lung cancer with a

    median follow-up of 21 months. Subjectsharbouring these lesions should also thereforebe followed up.

    Current smoking and a history of asbestosexposure were associated with an increased

    risk of such lesions. The findings suggest thatautofluorescencebronchoscopy is essential forsilicotic patients presenting with sputumabnormalities.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    15/16

    CONCLUSION

    Sputum examination followed by

    autoflourescence bronchoscopy

    may be a useful way of identifyingcancerous/pre cancerous lesions

    among silicotic smokers. Current

    smoking and asbestos exposure

    were associated with this lesions.

  • 7/30/2019 JR v.early Detection of Central Airway Lung Cancer in Smokers With Silicosis

    16/16

    THANK YOU